manilatimes.net

Pfizer Forecasts $9.7B Cost Savings and Beats Quarterly Results

Pfizer logoPfizer
Sig2.65Sen+4.15Env0.00Soc0.00Gov+1.05

Pfizer expects $9.7 billion in net savings from cost reductions through 2029 to offset declining Covid-related revenue and support sustainable growth. The company reported a quarterly results beat, with Eliquis and Padcev sales exceeding estimates, and lifted its full-year sales range to $60.5–$62.5 billion. CEO Bourla plans to keep the dividend and resume increases, while Dave Denton is set to leave as CFO as investors track late-stage cancer and obesity-drug data.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro